Crossmark

EFHD1 promotes osteosarcoma proliferation and drug resistance by inhibiting the opening of the mitochondrial membrane permeability transition pore (mPTP) by binding to ANT3

Crossref DOI link: https://doi.org/10.1007/s00018-024-05254-8

Published Online: 2024-05-25

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shen, Xin

Ma, Mengjun

Mi, Rujia

Zhuang, Jiahao

Song, Yihui

Yang, Wen

Li, Hongyu

Lu, Yixuan

Yang, Biao

Liu, Yinliang

Wu, Yanfeng

Shen, Huiyong https://orcid.org/0000-0002-4317-3468
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82102530, 82203740)

Natural Science Foundation of Guangdong Province (2022A1515010507, 2023A1515010552)

Outstanding Medical Innovation Talent Program of the Eighth Affiliated Hospital of Sun Yat-sen University (YYQ202103)

GuangDong Basic and Applied Basic Research Foundation (2021A1515110176)

Medical Scientific Research Foundation of Guangdong Province (A2022357)

Futian Healthcare Research Project (FTW2022031)

Shenzhen Science and Technology Program (JCYJ20230807111307015)
License Information

Text and Data Mining valid from 2024-05-25

Version of Record valid from 2024-05-25
More Information

Article History

Received: 7 August 2023

Revised: 19 March 2024

Accepted: 24 April 2024

First Online: 25 May 2024

Declarations

:

: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

: This study was approved by the Ethics Committee of the Eighth Affiliated Hospital, Sun Yat-sen University, China. All animal experimental procedures were approved by the institutional animal care and use committee of Sun Yat-Sen University, China.

: Informed consent was obtained from all individual participants included in the study.

Document is current

Any future updates will be listed below